Aflatoxins as risk factors for hepatocellular carcinoma in humans.
about
Mutational signatures: the patterns of somatic mutations hidden in cancer genomesGlutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.Histological lesions, cell cycle arrest, apoptosis and T cell subsets changes of spleen in chicken fed aflatoxin-contaminated corn.Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x proteinAflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma.Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisinAromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinomaChemical exposure as etiology in developmental origin of adult onset human cancer.Mutation signatures implicate aristolochic acid in bladder cancer developmentCryptic speciation and recombination in the aflatoxin-producing fungus Aspergillus flavus.Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.Calcium montmorillonite clay reduces urinary biomarkers of fumonisin B₁ exposure in rats and humans.Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats.Association between Aflatoxin M₁ and Liver Disease in HBV/HCV Infected Persons in Ghana.Evaluation of The Number of CD4(+) CD25(+) FoxP3(+) Treg Cells in Normal Mice Exposed to AFB1 and Treated with Aged Garlic Extract.Aspergillus has distinct fatty acid synthases for primary and secondary metabolism.Growth-Phase Sterigmatocystin Formation on Lactose Is Mediated via Low Specific Growth Rates in Aspergillus nidulans.EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.Effects of dietary selenium on histopathological changes and T cells of spleen in broilers exposed to aflatoxin B1.Inhibition of aflatoxin synthesis in Aspergillus flavus by three structurally modified lentinans.Twenty-five coregulated transcripts define a sterigmatocystin gene cluster in Aspergillus nidulans.Current understanding on aflatoxin biosynthesis and future perspective in reducing aflatoxin contamination.An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.Revitalization of a Forward Genetic Screen Identifies Three New Regulators of Fungal Secondary Metabolism in the Genus Aspergillus.Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancerResponse of Intestinal Bacterial Flora to the Long-term Feeding of Aflatoxin B1 (AFB1) in Mice.Achievements and Prospects in Electrochemical-Based Biosensing Platforms for Aflatoxin M₁ Detection in Milk and Dairy Products.Analysis of the Relationship between Alternative Respiration and Sterigmatocystin Formation in Aspergillus nidulans.What is the meaning of 'A compound is carcinogenic'?Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.
P2860
Q26850125-962724A2-367D-4B99-B900-4EAD8E245CF9Q28508275-F7570186-3459-43F2-B323-AC8A2E8E74A7Q30249783-F5FF2325-1167-4675-9A34-8DCE83922801Q30479629-970925EC-6FAC-45DF-B709-C7F461A4D7F3Q33989690-4942FC63-6C7A-4AA8-80F4-B201BCBF3C7DQ34086219-4310A909-98F9-4AF8-B705-46085415F03DQ34355312-A2B304D5-C603-4BF2-8598-C4A0815E144DQ34359674-EC5B4204-D2F8-42CD-A5FB-3BB75136EC06Q34639833-319D28B1-6F66-476B-955E-B6FFF4591118Q34652372-C9405FE0-436E-4C14-A222-C63C628948E8Q35112903-B760DC35-CD4D-4B98-BE6A-1A2D5A109F38Q35619948-CE4C9552-04E3-4E9C-B0E7-73E4AA1D5355Q35646186-F208BC04-EC57-4D4F-A47F-6481EACAE61EQ35680920-BA3BBA86-A6C7-48FF-8049-5A5E53BAB57BQ35870353-76820A67-B676-447F-9844-1BAB22A16C70Q36070950-850C6202-3881-43B0-8A81-8DBC8FFC7EDCQ36180517-6D91244B-C226-44DE-AEBD-94C111BE7C14Q36841640-A911DF00-8660-4E70-944A-676FD4F8D85AQ36862631-6F6EB0C5-86E6-4233-89D1-9E06727DC76AQ37055265-227625A7-5F30-4AB6-BE82-D1F8DAA358B4Q37542637-0DADBF1E-CDD8-4AC9-9D0E-CB36B3AC491DQ37552436-A66CB85A-96E5-4857-B332-FA5630505C3EQ37623042-693FB545-8DE1-498A-8986-F4B997AC9879Q37684001-1C148B24-A76C-46C8-93A4-81AEB355B851Q37716071-BCB37ED6-439A-497E-866A-74FCF71FB24EQ38064273-D00F3AC5-EE80-47AB-B8E6-A1C962FF0E0BQ38823495-11C3185B-EF1E-4FE5-A0DA-21DEFCC3710EQ41128742-3516CACD-24F8-4552-8414-707C9BC2E0FEQ41622502-443EE295-8748-4B8D-8F51-32C1EE8B8E79Q42428773-E04E9395-E343-4F3D-9057-331AE689F31BQ43074748-53364E72-F436-447F-9442-8F3801F77A23Q48094869-2622DF3E-FEF0-4798-8B7A-C726A4ED46FFQ53693297-DAE30A29-29E8-4DB6-B01E-A942B6E7D046Q55074220-E04BCBB5-4BA6-4571-B759-01BB1CC7267EQ55515016-A3253378-0508-4B5E-ADED-8C1194C8A604
P2860
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@ast
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@en
type
label
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@ast
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@en
prefLabel
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@ast
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@en
P1433
P1476
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
@en
P2093
P304
2114s-2118s
P407
P433
P577
1992-04-01T00:00:00Z